Top in rheumatology: Dermatomyositis prevalence, self-management of arthritis
Click Here to Manage Email Alerts
Recent data found that dermatomyositis was more prevalent than had been thought. The retrospective, population-based cohort study that led to this conclusion was the top story in rheumatology last week.
The second top story reported on CDC data that indicated that fewer than 20% of U.S. adults with arthritis had ever attended a self-management class, while almost 70% of the same population group had received counseling for physical activity.
Read these and more top stories in rheumatology below:
Dermatomyositis incidence, prevalence higher than previously reported
Using the most recent European Alliance of Associations for Rheumatology/American College of Rheumatology criteria, researchers at the Mayo Clinic and the Karolinska Institute determined that the incidence and prevalence of dermatomyositis are higher than previously reported. Read more.
Less than 20% of adults with arthritis attend self-management classes
A median of just 16.2% of adults with arthritis attended a self-management class in 2019, while that same year 69.3% received counseling for physical activity from their provider, according to CDC researchers. Read more.
Collaboration in 'specialized PsA center' significantly reduces time to diagnosis
A university psoriatic arthritis center focusing on close collaboration between rheumatologists and dermatologists helped significantly decrease time to diagnosis, according to data published in BMC Rheumatology. Read more.
Colchicine fails to reduce COVID-19 severity, risk for death
Adding colchicine to the standard care regimen for COVID-19 fails to decrease disease severity or reduce the risk for death in hospitalized patients, according to a meta-analysis published in RMD Open. Read more.
Vascular ultrasound may offer first-line alternative for diagnosing giant cell arteritis
Vascular ultrasound, using high-end equipment and optimized settings, may be an effective replacement for temporal artery biopsy as a first-line diagnostic tool in patients with suspected giant cell arteritis, according to a Danish study. Read more.